UCI Health Launches Therapeutic Clinical Trial for COVID-19 | KCET
UCI Health Launches Therapeutic Clinical Trial for COVID-19
ORANGE (CNS) - UCI Health clinicians have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2), which has reached pandemic levels across the globe, UC Irvine announced today.
There are no specific therapeutics approved by the Food and Drug Administration to treat people with COVID-19. The infection can cause mild to severe respiratory illness, and symptoms can include fever, cough and shortness of breath. In older adults and immunocompromised patients with the condition can develop into severe pneumonia.
"There is currently no safe, effective treatment for COVID-19," said Dr. Alpesh N. Amin, chair of the Department of Medicine, UCI School of Medicine and executive director, UCI Health Hospitalist Program. "While remdesivir has shown some promise, we need solid clinical data that indicates it improves outcomes for infected patients."
Amin and infectious disease specialist, Dr. Hsieh, are principal investigators at UCI and will oversee the randomized, placebo-controlled trial. UCI, along with UC San Diego and UC Davis, are designated sites for the first NAIAD-sponsored remdesivir clinical trials in California. The trial enrolled its first patients in late February at the University of Nebraska Medical Center.
more on covid-19
As Orange County's only academic health system, UCI Health and UCI Medical Center are well-equipped to manage the care of patients with infectious diseases. UCI experts have planned since early January to prepare the medical center's staff and facilities to treat patients infected with SARS-CoV-2.
The Orange County Health Care Agency has reported 53 confirmed cases of COVID-19.
Remdesivir, developed by Gilead Sciences Inc., is an investigational broad-spectrum antiviral treatment. It was previously tested in humans with Ebola virus disease and has shown promise in animal models for treating Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), which are caused by other coronaviruses.
COVID-19 was first detected in December 2019 in Wuhan, China. SARS emerged in China and infected more than 8,000 people in 2002 and 2003. MERS emerged in Saudi Arabia in 2012. Through December 2019, the World Health Organization had confirmed 2,499 MERS-CoV cases and 861 deaths (or about 1 in 3), according to the NIAID.
According to the NIAID, participants in the NIH-sponsored trial must have laboratory-confirmed SARS-CoV-2 infection and evidence of lung involvement, including rattling sounds when breathing with a need for supplemental oxygen or abnormal chest X-rays, or illness requiring mechanical ventilation. Individuals with confirmed infection who have mild, cold-like symptoms or no apparent symptoms will not be included in the study.
It's time to vote! Get fired up to hit the polls, ballot drop boxes and voting centers Nov. 3 with this hilarious PSA from Culture Clash.
Young people have a pivotal role in some of today's biggest issues. See how their voices have helped shaped movements around the world.
Halloween 2020 is not canceled. It’s just a little different this year. Whether it’s established attractions or inaugural events that might become future Halloween standbys, here are five great ways to scare up some extra spooks this October.
Universal CityWalk and Cal State Northridge were announced as the latest venues that will serve as vote centers for Los Angeles County residents to cast their ballots in the November election.
- 1 of 373
- next ›
Take a rare behind-the-scenes look inside the busiest fire station in the country, where firefighters act as both primary care providers and emergency responders for the nearly 5,000 people living on Skid Row.
In 2019, California, one of the nation’s most secretive states when it comes to police files, put SB1421 into effect. But a year into the new transparency law, journalists and the public are realizing that the law may not be as transparent as expected.
State and local regulators are overwhelmed and outgunned when it comes to closing down California’s poisonous pot pipeline.
Parents are willing to spend thousands to get the competitive edge in the college admissions process, but at what cost? Socal Connected takes a revealing look at the high stakes world of the for-profit education consultant business.
Socal Connected looks at what happened to LA Jets’ Obea Moore and the current state of youth track and field today.
- 1 of 54
- next ›